Timothy Y Mariano1,2, Frederick W Burgess3, Marguerite Bowker3, Jason Kirschner1,3,4, Mascha Van't Wout-Frank3,4, Richard N Jones1,3,4, Christopher W Halladay3, Michael Stein1,5, Benjamin D Greenberg1,3,4. 1. Butler Hospital, Providence, Rhode Island. 2. Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Center for Neurorestoration and Neurotechnology, Providence Veterans Affairs Medical Center, Providence, Rhode Island. 4. Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island. 5. Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts, USA.
Abstract
BACKGROUND AND OBJECTIVE:Chronic low back pain (CLBP) is highly prevalent, with a substantial psychosocial burden. Pain has both sensory and affective components. The latter component is a significant driver of disability and psychiatric comorbidity but is often inadequately treated. Previously we reported that noninvasive transcranial direct current stimulation (tDCS) may modulate pain-associated affective distress. Here we tested whether 10 daily tDCS sessions aimed to inhibit the left dorsal anterior cingulate cortex (dACC), a region strongly implicated in the affective component of pain, would produce selective reduction in pain-related symptoms. METHODS: In this multisite, double-blinded, randomized placebo-controlled trial (RCT), 21 CLBP patients received 10 weekday sessions of 2-mA active tDCS or sham (20 minutes/session). A cathodal electrode was placed over FC1 (10-20 electroencephalography coordinates), and an identical anodal return electrode was placed over the contralateral mastoid. Participants rated pain intensity, acceptance, interference, disability, and anxiety, plus general anxiety and depression. RESULTS: Regression analysis noted significantly less pain interference (P =0.002), pain disability (P =0.001), and depression symptoms (P =0.003) at six-week follow-up for active tDCS vs sham. Omnibus tests suggested that these improvements were not merely due to baseline (day 1) group differences. CONCLUSIONS: To our knowledge, this is the first double-blinded RCT of multiple tDCS sessions targeting the left dACC to modulate CLBP's affective symptoms. Results are encouraging, including several possible tDCS-associated improvements. Better-powered RCTs are needed to confirm these effects. Future studies should also consider different stimulation schedules, additional cortical targets, high-density multi-electrode tDCS arrays, and multimodal approaches.
RCT Entities:
BACKGROUND AND OBJECTIVE:Chronic low back pain (CLBP) is highly prevalent, with a substantial psychosocial burden. Pain has both sensory and affective components. The latter component is a significant driver of disability and psychiatric comorbidity but is often inadequately treated. Previously we reported that noninvasive transcranial direct current stimulation (tDCS) may modulate pain-associated affective distress. Here we tested whether 10 daily tDCS sessions aimed to inhibit the left dorsal anterior cingulate cortex (dACC), a region strongly implicated in the affective component of pain, would produce selective reduction in pain-related symptoms. METHODS: In this multisite, double-blinded, randomized placebo-controlled trial (RCT), 21 CLBPpatients received 10 weekday sessions of 2-mA active tDCS or sham (20 minutes/session). A cathodal electrode was placed over FC1 (10-20 electroencephalography coordinates), and an identical anodal return electrode was placed over the contralateral mastoid. Participants rated pain intensity, acceptance, interference, disability, and anxiety, plus general anxiety and depression. RESULTS: Regression analysis noted significantly less pain interference (P =0.002), pain disability (P =0.001), and depression symptoms (P =0.003) at six-week follow-up for active tDCS vs sham. Omnibus tests suggested that these improvements were not merely due to baseline (day 1) group differences. CONCLUSIONS: To our knowledge, this is the first double-blinded RCT of multiple tDCS sessions targeting the left dACC to modulate CLBP's affective symptoms. Results are encouraging, including several possible tDCS-associated improvements. Better-powered RCTs are needed to confirm these effects. Future studies should also consider different stimulation schedules, additional cortical targets, high-density multi-electrode tDCS arrays, and multimodal approaches.
Authors: Zeinab Esmaeilpour; Paola Marangolo; Benjamin M Hampstead; Sven Bestmann; Elisabeth Galletta; Helena Knotkova; Marom Bikson Journal: Brain Stimul Date: 2017-12-13 Impact factor: 8.955
Authors: W J Spangler; G R Cosgrove; H T Ballantine; E H Cassem; S L Rauch; A Nierenberg; B H Price Journal: Neurosurgery Date: 1996-06 Impact factor: 4.654
Authors: Ali R Mansour; Marwan N Baliki; Lejian Huang; Souraya Torbey; Kristi M Herrmann; Thomas J Schnitzer; A Vania Apkarian Journal: Pain Date: 2013-10 Impact factor: 6.961
Authors: Colleen K Loo; Mustafa M Husain; William M McDonald; Scott Aaronson; John P O'Reardon; Angelo Alonzo; Cynthia Shannon Weickert; Donel M Martin; Shawn M McClintock; Adith Mohan; Sarah H Lisanby Journal: Brain Stimul Date: 2017-10-27 Impact factor: 8.955
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Chester C Buckenmaier; Kevin T Galloway; Rosemary C Polomano; Mary McDuffie; Nancy Kwon; Rollin M Gallagher Journal: Pain Med Date: 2012-11-08 Impact factor: 3.750
Authors: Vishal Rawji; Matteo Ciocca; André Zacharia; David Soares; Dennis Truong; Marom Bikson; John Rothwell; Sven Bestmann Journal: Brain Stimul Date: 2017-11-07 Impact factor: 8.955
Authors: Divya Bharatkumar Adhia; Ramakrishnan Mani; John N J Reynolds; Sven Vanneste; Dirk De Ridder Journal: BMJ Open Date: 2022-06-15 Impact factor: 3.006